Competing interests
G.M.v.D. is CEO of Tracer Europe B.V./AxelaRx. B.v.d.V. is a member of the Scientific Advisory Board of Visiopharm, for which compensation is received by the University Medical Centre Groningen. The remaining authors declare no competing interests.